https://ogma.newcastle.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Alzheimer's disease patient groups derived from a multivariate analysis of cognitive test outcomes in the coalition against major diseases dataset https://ogma.newcastle.edu.au/vital/access/manager/Repository/uon:25160 Wed 11 Apr 2018 16:09:03 AEST ]]> The IMPAKT of breast cancer research: fundamental science and clinical medicine https://ogma.newcastle.edu.au/vital/access/manager/Repository/uon:23667 Wed 11 Apr 2018 12:36:34 AEST ]]> A simplified method to calculate telomere length from Southern blot images of terminal restriction fragment lengths https://ogma.newcastle.edu.au/vital/access/manager/Repository/uon:38373 80% of 18 samples as having short, medium or long telomeres compared with 33–72% using other methods.]]> Wed 01 Sep 2021 12:47:32 AEST ]]> MAPK pathway: a potential target for the treatment of non-small-cell lung carcinoma https://ogma.newcastle.edu.au/vital/access/manager/Repository/uon:48577 Tue 21 Mar 2023 17:30:00 AEDT ]]> An overview of vaccine development for COVID-19 https://ogma.newcastle.edu.au/vital/access/manager/Repository/uon:46318 Tue 15 Nov 2022 11:45:52 AEDT ]]> Formulation and characterization of glibenclamide and quercetin-loaded chitosan nanogels targeting skin permeation https://ogma.newcastle.edu.au/vital/access/manager/Repository/uon:42198 Thu 25 Aug 2022 11:34:49 AEST ]]> Immunological axis of curcumin-loaded vesicular drug delivery systems https://ogma.newcastle.edu.au/vital/access/manager/Repository/uon:33591 Thu 22 Nov 2018 13:41:26 AEDT ]]> Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549 https://ogma.newcastle.edu.au/vital/access/manager/Repository/uon:38589 Fri 12 Nov 2021 15:59:30 AEDT ]]>